The object of the invention is to provide a novel compound having an inhibitory action on PDE4 activity with fewer side effects.
The invention provides a compound represented by the following general formula (1), possible stereoisomers thereof or racemates thereof, pharmacologically acceptable salts thereof, hydrates thereof, solvated compounds thereof, or prodrugs thereof,